The study, however, did not assess Delta and other variants.
Cancer activists are now calling on government to prioritise vaccines for younger cancer patients and their caregivers.
In a new study, cancer patients developed a good immune response to Covid-19 mRNA vaccines three to four weeks after they received their second dose.
The research published in
Cancer Cell assessed Covid-19 positivity and antibodies in a small group of cancer patients after receiving two doses of the Pfizer or Moderna vaccine.
Immunity in cancer patients
The study enrolled 131 cancer patients from the United States and Sweden from January to April 2021. None of the participants had previous antibodies against the virus.
Study suggests patients with cancer respond well to COVID-19 vaccines
aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
Cancer patients respond well to COVID-19 vaccines
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
TORONTO A new international study suggests that 94 per cent of cancer patients experienced an immune response after being vaccinated with either Pfizer or Moderna â but it only became a strong response after a second dose, reiterating the importance of cancer patients receiving both doses. How effective vaccines are for those who are undergoing cancer treatments has been a source of concern and confusion throughout the pandemic, as vaccines for other diseases have been known to have different impacts on cancer patients. But according to this U.S. and Swiss study, published in June in the journal Cancer Cell, by the time a cancer patient has received both doses, they largely receive a similar level of protection as the general population, with some exceptions.